Public consultation on interim decisions to amend the Poisons Standard - ACMS #40 NOVEMBER 2022 (paracetamol)

Closed 3 Mar 2023

Opened 3 Feb 2023

Feedback updated 3 May 2023

We asked

Between 3 February 2023 and 3 March 2023, we sought submissions from the public on the Delegate’s interim decision on paracetamol. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

A total of 201 submissions were received in response to the Delegate’s interim decision. The breakdowns of the responses are shown below:

In support of the interim decision: A total of 9 responses were received in support, 6 of which contained written responses.

In partial support of the interim decision: A total of 33 responses were received in partial support, all of which contained a written component.

In opposition to the interim decision: A total of 159 responses were received in opposition to the proposed amendment, 136 of which contained written responses.

We did

The Delegate considered all submissions prior to making their final decision on paracetamol. The final decision for paracetamol was published on 3 May 2023.

Published responses

View submitted responses where consent has been given to publish the response.


Interim decisions regarding substances discussed at the expert advisory meetings. 

Please note that this consultation is for the interim decision in relation to paracetamol only. If you wish to comment on the interim decisions for other substances discussed at the November 2022 meetings, please see the link below:

This consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).

Kindly note that the interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 3 MARCH 2023. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions November 2023 (including paracetamol) which can be accessed below: 

Substance for which public comment is sought in this consultation:

  • Paracetamol 

A questions and answers page regarding the interim decision on paracetamol is also available.

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Local governments
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • Aged care service providers
  • Aged care workforce
  • Aged care professionals
  • BPRU staff
  • Graduates
  • Online and Publications staff
  • Secretariat
  • PCCD
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biologicals
  • Other


  • Policy Development